Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 6.12837 | 84 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 6.16368 | 83 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 6.10402 | 83 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.91179 | 81 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 6.17221 | 83 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 6.3982 | 87 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 6.66047 | 88 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 6.38626 | 85 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 6.49703 | 86 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 6.19302 | 84 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 6.19903 | 84 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 6.18229 | 83 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 6.17739 | 84 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 6.26653 | 85 |